These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators. Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343 [TBL] [Abstract][Full Text] [Related]
7. Muscarinic acetylcholine receptor binding affinities of pethidine analogs. Lee NR; Zhang X; Darna M; Dwoskin LP; Zheng G Bioorg Med Chem Lett; 2015 Nov; 25(22):5032-5. PubMed ID: 26494260 [TBL] [Abstract][Full Text] [Related]
8. Continued optimization of the M McGowan KM; Nance KD; Cho HP; Bridges TM; Conn PJ; Jones CK; Lindsley CW Bioorg Med Chem Lett; 2017 Mar; 27(6):1356-1359. PubMed ID: 28237763 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of M Gunter BW; Gould RW; Bubser M; McGowan KM; Lindsley CW; Jones CK Addict Biol; 2018 Sep; 23(5):1106-1116. PubMed ID: 29044937 [TBL] [Abstract][Full Text] [Related]
11. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor. Grant MK; El-Fakahany EE J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459 [TBL] [Abstract][Full Text] [Related]
12. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer. Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301 [TBL] [Abstract][Full Text] [Related]
13. Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M Lee NR; Gujarathi S; Bommagani S; Siripurapu K; Zheng G; Dwoskin LP Bioorg Med Chem Lett; 2019 Feb; 29(3):471-476. PubMed ID: 30554957 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Miyoshi S; Tu AT Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446 [TBL] [Abstract][Full Text] [Related]
15. Novel allosteric effects of amiodarone at the muscarinic M5 receptor. Stahl E; Ellis J J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203 [TBL] [Abstract][Full Text] [Related]
16. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding. Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238 [TBL] [Abstract][Full Text] [Related]
18. Characterization of methanthelinium binding and function at human M Irmen M; Holze J; Bödefeld T; Tränkle C Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1037-1052. PubMed ID: 29938305 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists. Wang Y; Chackalamannil S; Chang W; Greenlee W; Ruperto V; Duffy RA; McQuade R; Lachowicz JE Bioorg Med Chem Lett; 2001 Apr; 11(7):891-4. PubMed ID: 11294385 [TBL] [Abstract][Full Text] [Related]
20. The optimization of a novel selective antagonist for human M Li M; Huang C; Wu X; Ding F; Hu Z; Zhu Y; Zhao L; Hou L; Chen H; Wang H; Xu J; Tang D Bioorg Med Chem Lett; 2020 Dec; 30(24):127632. PubMed ID: 33132116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]